Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 29.24B |
| Enterprise value | 33.07B |
| Trailing P/E | 20.44 |
| Forward P/E | 12.47 |
| PEG ratio (5-yr expected) | 8.48 |
| Price/sales (ttm) | 2.74 |
| Price/book (mrq) | 2.60 |
| Enterprise value/revenue | 3.06 |
| Enterprise value/EBITDA | 12.11 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.42 |
| 52-week change 3 | -24.31% |
| S&P500 52-week change 3 | -5.29% |
| 52-week high 3 | 468.55 |
| 52-week low 3 | 187.16 |
| 50-day moving average 3 | 206.76 |
| 200-day moving average 3 | 246.33 |
Share statistics
| Avg vol (3-month) 3 | 1.1M |
| Avg vol (10-day) 3 | 1.03M |
| Shares outstanding 5 | 146.45M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 146.03M |
| % held by insiders 1 | 0.63% |
| % held by institutions 1 | 86.49% |
| Shares short (12 May 2022) 4 | 2.2M |
| Short ratio (12 May 2022) 4 | 1.8 |
| Short % of float (12 May 2022) 4 | 1.69% |
| Short % of shares outstanding (12 May 2022) 4 | 1.50% |
| Shares short (prior month 13 Apr 2022) 4 | 1.93M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 3:1 |
| Last split date 3 | 17 Jan 2001 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 13.40% |
| Operating margin (ttm) | 28.59% |
Management effectiveness
| Return on assets (ttm) | 8.15% |
| Return on equity (ttm) | 14.09% |
Income statement
| Revenue (ttm) | 10.82B |
| Revenue per share (ttm) | 73.15 |
| Quarterly revenue growth (yoy) | -6.00% |
| Gross profit (ttm) | 8.87B |
| EBITDA | 3.62B |
| Net income avi to common (ttm) | 1.45B |
| Diluted EPS (ttm) | 9.77 |
| Quarterly earnings growth (yoy) | -25.90% |
Balance sheet
| Total cash (mrq) | 3.75B |
| Total cash per share (mrq) | 25.62 |
| Total debt (mrq) | 7.59B |
| Total debt/equity (mrq) | 67.62 |
| Current ratio (mrq) | 2.01 |
| Book value per share (mrq) | 76.22 |
Cash flow statement
| Operating cash flow (ttm) | 3.03B |
| Levered free cash flow (ttm) | 2.08B |
© 2022 Yahoo. All rights reserved.
